openPR Logo
Press release

Hemoglobinopathies Market Driven by Extensive Research and Development Activities

05-11-2016 02:39 PM CET | Health & Medicine

Press release from: Transparency Market Research

Hemoglobinopathies Market Driven by Extensive Research

Global Hemoglobinopathies Market: Description

The U.S. National Library of Medicine defines hemoglobinopathy as a group of disorders passed down from one generation to another that are characterized by an abnormal structure or production of the hemoglobin molecule. Hemoglobinopathy disorders include sickle cell anemia, hemoglobin C disease, hemoglobin S-C disease, and various forms of thalassaemia. The growing prevalence of hemoglobinopathy disorders, particularly sickle cell anemia, has boosted the growth of the global hemoglobinopathies market.

Browse Full Report : http://www.transparencymarketresearch.com/hemoglobinopathies-market.html

Though the prevalence of hemoglobinopathies is high across under-developed economies, including countries in Southeast Asia and the Sub-Saharan region, the global hemoglobinopathies market is expected to grow across developed and developing economies in North America and Asia Pacific, respectively, due to better health care infrastructure. The introduction of advanced diagnostics and therapeutics will likely boost the growth of the market in the coming years. Genetic testing, blood testing, pre-implantation genetic diagnosis, prenatal genetic testing, and hemoglobin electrophoresis are some of the key diagnostics for identifying hemoglobinopathies disorders. Iron chelation therapy, blood transfusion, hydroxyurea, and bone marrow transplant are the common therapies available in the market. Research and development activities and regulatory support are shaping the future of the global hemoglobinopathies market.

Global Hemoglobinopathies Market: Overview

Among various hemoglobinopathy disorders, sickle cell anemia is the most common inherited blood disease. According to the World Health Organization (WHO), around 5% of the world’s population carries trait genes for hemoglobinopathy disorders such as thalassaemia and sickle cell anemia. While sickle cell anemia is most common across Africa, various forms of thalassaemia are prevalent in the Middle East, the Mediterranean basin, and Asia. In sickle cell disease, the half-moon shape of red blood cells causes poor blood oxygen levels and blood vessel blockages. This leads to anemia among the patients.

The rapid rise in the number of people affected by the disease has led governments and regulatory authorities to initiate awareness programs to decrease hemoglobinopathy-related mortality rates. For example, in 2010, the Centers for Disease Control and Prevention (CDC) started the Thalassaemia Data Collection Project and Blood Safety Monitoring. All these factors are expected to positively impact the growth of the global hemoglobinopathies market.

Further, the increased awareness about genetic testing for diagnosis of sickle cell anemia and other hemoglobinopathy disorders is anticipated to contribute significantly toward the growth of the market in the near future. Genetic testing has emerged as the most cost-effective strategy to reduce the prevalence of hemoglobinopathy disorders.

Global Hemoglobinopathies Market: Region-wise Outlook

The global hemoglobinopathies market has been segmented into four key regions: Asia Pacific, Europe, North America, and Rest of the World. Sickle cell anemia is most common in Central and West Africa where about 25% of the population has sickle cell trait and around 1%-2% of all babies are born with a form of the disease. In North America, particularly in the U.S., where the population is estimated to be over 270 million, around 1,000 babies are born with sickle cell disease every year. The growing prevalence of various hemoglobinopathy disorders, along with a high level of awareness about hemoglobinopathy-related genetic testing has propelled the growth of the hemoglobinopathies market in North America. However, in the coming years, improving health care infrastructure in Asia Pacific and introduction of low-cost diagnostic alternatives are projected to boost the growth of the market in the region.

Request A Sample Of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=10676

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:
•Market segments and sub-segments
•Market trends and dynamics
•Supply and demand
•Market size
•Current trends/opportunities/challenges
•Competitive landscape
•Technological breakthroughs
•Value chain and stakeholder analysis
T
he regional analysis covers:
•North America (U.S. and Canada)
•Latin America (Mexico, Brazil, Peru, Chile, and others)
•Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries,

Belgium, Netherlands, Luxembourg)
•Eastern Europe (Poland, Russia)
•Asia Pacific (China, India, Japan, ASEAN, Australia and New Zealand)
•Middle East and Africa (GCC, Southern Africa, North Africa)

About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email:Â sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hemoglobinopathies Market Driven by Extensive Research and Development Activities here

News-ID: 340541 • Views: 549

More Releases from Transparency Market Research

Packaged Vegan Foods Market Size, Review, Key Findings, Growth Strategy, Develop …
Consumers focusing on cutting down the animal based dairy products have started preferring packaged vegan food. Packaged vegan food are prepared without the use of any animal based ingredients resulting in low fat and cholesterol. Increasing number of people are now a days turning vegan because of their love and compassion toward animals and the environment. Obtain Report Details @ https://www.transparencymarketresearch.com/packaged-vegan-foods-market.html One of the major driving factor of packaged vegan food is
Hot Sauce industry Insights By Size , Status, Trends, Developments, Opportunitie …
The hot sauce market has witnessed immense growth pace across a number of other regional markets as well, where Asian cuisine is rapidly becoming the choice of youngsters. It is estimated that the market will continue to thrive in the near future and witness surging demand as new uses of hot sauce in native culinary styles of a number of countries are invented and adopted. The global market for hot sauce
Growth Opportunities in the Processed Fish Industry - Development, Trends, Key D …
Fish is one of the delicate food which demands proper handling for a long shelf life so that it do not lose its nutritional value and desired quality, the primary concern from which fish is to be protected is the deterioration issue. Many contributors are involved in fish processing such as fishermen, fish sourcing suppliers, seafood processors, manufacturers, logistics and distribution, marketing & sales, and end-use industries or consumers. Hence
Tea Tea Based Beverages Industry Size- Global Overview, Growth, Size, Opportunit …
The global tea and tea-based beverages market is anticipated to register a relatively higher compound annual growth rate of 4.9% in terms of revenue during the time frame of the forecast period, due to various market dynamics, regarding which, TMR offers detailed insights. Transparency Market Research provides key detailed insights into the global tea and tea-based beverages market, in its upcoming market outlook titled, 'Tea and Tea-Based Beverages Market: Global

All 5 Releases


More Releases for Hemoglobinopathies

World Hemoglobinopathies Market - Opportunities and Forecasts, 2017-2023
Hemoglobinopathy is a genetic disorder that causes structural abnormalities in hemoglobin molecules, particularly defective globin chains. Hemoglobinopathies are inherited single-gene disorders of which sickle cell disease is the most common kind. There is a high prevalence of Hemoglobinopathies in Africa, Southeast Asia and the Mediterranean basin. If left untreated, critical cases of hemoglobinopathies lead to anemia, organ dysfunction or death. Gel electrophoresis and complete blood count are used as diagnostic
Hemoglobinopathies Market to Develop Rapidly by 2024
The U.S. National Library of Medicine defines hemoglobinopathy as a group of disorders passed down from one generation to another that are characterized by an abnormal structure or production of the hemoglobin molecule. Hemoglobinopathy disorders include sickle cell anemia, hemoglobin C disease, hemoglobin S-C disease, and various forms of thalassaemia. The growing prevalence of hemoglobinopathy disorders, particularly sickle cell anemia, has boosted the growth of the global Hemoglobinopathies Market. Though the
Hemoglobinopathies Market Key Growth Factors and Forecast Upto 2024
The U.S. National Library of Medicine defines hemoglobinopathy as a group of disorders passed down from one generation to another that are characterized by an abnormal structure or production of the hemoglobin molecule. Hemoglobinopathy disorders include sickle cell anemia, hemoglobin C disease, hemoglobin S-C disease, and various forms of thalassaemia. The growing prevalence of hemoglobinopathy disorders, particularly sickle cell anemia, has boosted the growth of the global hemoglobinopathies market. Report Overview
04-20-2017 | Health & Medicine
TMR
Growing Prevalence of Hemoglobinopathy Disorders Boost the Growth of the Global …
The U.S. National Library of Medicine defines hemoglobinopathy as a group of disorders passed down from one generation to another that are characterized by an abnormal structure or production of the hemoglobin molecule. Hemoglobinopathy disorders include sickle cell anemia, hemoglobin C disease, hemoglobin S-C disease, and various forms of thalassaemia. The growing prevalence of hemoglobinopathy disorders, particularly sickle cell anemia, has boosted the growth of the global hemoglobinopathies market. Though the
Hemoglobinopathies Market – Industry Analysis, Share, Research Report 2023
Hemoglobinopathies Market size is driven by high occurrence in underdeveloped nations such as Arab nations, Sub-Saharan region and South East Asia. Hemoglobinopathies Market size was valued at over USD 4 billion in 2015. Other key reasons for disease prevalence include lack of patient awareness, unmet needs for treatment, and absence of permanent cure. Lack of awareness for treatment and diagnosis of such rare diseases generates huge untouched opportunities in the industry.
Hemoglobinopathies Market - Global Industry Analysis 2016 - 2024
Global Hemoglobinopathies Market: Overview Among various hemoglobinopathy disorders, sickle cell anemia is the most common inherited blood disease. According to the World Health Organization (WHO), around 5% of the world’s population carries trait genes for hemoglobinopathy disorders such as thalassaemia and sickle cell